Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain
Sicras-Mainar, Antoni, Rejas, Javier, Navarro-Artieda, Ruth, Aguado-Jodar, Alba, Ruiz-Torrejón, Amador, Ibáñez-Nolla, Jordi, Kvasz, MarionVolume:
13
Language:
english
Journal:
BMC Urology
DOI:
10.1186/1471-2490-13-51
Date:
December, 2013
File:
PDF, 377 KB
english, 2013